Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AVAH
AVAH logo

AVAH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
6.565
Open
6.450
VWAP
6.49
Vol
901.48K
Mkt Cap
1.42B
Low
6.390
Amount
5.85M
EV/EBITDA(TTM)
9.91
Total Shares
217.51M
EV
2.69B
EV/OCF(TTM)
21.33
P/S(TTM)
0.57
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
Show More

Events Timeline

(ET)
2026-03-19
16:30:00
Major Averages Close Lower as Investors Digest Fed Policy
select
2026-03-19
12:00:00
Major Averages Broadly Lower Near Noon
select
2026-03-19
07:20:00
Aveanna Reports Q4 Revenue of $662.5M, Beating Expectations
select
2026-03-19
07:20:00
Aveanna Reports 20.2% Revenue Growth and 74.8% EBITDA Growth for 2025
select

News

Newsfilter
9.5
04-23Newsfilter
PinnedAveanna Healthcare to Release Q1 Results
  • Earnings Release Schedule: Aveanna Healthcare will announce its Q1 financial results before market open on May 14, 2026, followed by a conference call at 10:00 a.m. ET, reflecting the company's commitment to transparency and investor communication.
  • Conference Call Access: Investors can join the call by dialing 1-877-407-0789 (international callers: 1-201-689-8562), with a replay available three hours post-call until May 21, ensuring timely access to critical information for stakeholders.
  • Webcast Option: The call will also be available via a live webcast on the company's Investor Relations website, with the replay accessible for one week after the event, enhancing information accessibility and transparency for investors.
  • Company Overview: Headquartered in Atlanta, Georgia, Aveanna Healthcare offers a wide range of services including nursing, rehabilitation, and home health care, aiming to provide high-quality, lower-cost alternatives to prolonged hospitalization, showcasing the company's diversity and expertise in the healthcare sector.
seekingalpha
9.5
03-19seekingalpha
Aveanna Healthcare Reports Strong Q4 2025 Earnings with Strategic Growth Plans
  • Significant Revenue Growth: Aveanna Healthcare reported approximately $662.5 million in Q4 2025 revenue, marking a 27.4% year-over-year increase, with full-year revenue reaching about $2.433 billion, showcasing the company's strong growth potential under its preferred payer strategy.
  • Outstanding EBITDA Performance: The adjusted EBITDA for Q4 was $85 million, up 54% year-over-year, reflecting the company's success in operational efficiency and cost control, with expectations for 2026 EBITDA to remain between $318 million and $322 million.
  • Acquisition Plans Advancing: The company announced the acquisition of Family First Homecare, expected to close in Q2 2026, which is anticipated to enhance its market presence in Florida, alongside plans to add eight new preferred payer agreements in 2026, targeting a total of 38 by year-end.
  • Optimistic Future Outlook: Management projects 2026 revenue in the range of $2.54 billion to $2.56 billion, emphasizing a continued focus on technology investments and operational efficiency to support future growth strategies.
seekingalpha
9.5
03-19seekingalpha
Aveanna Healthcare Shares Plunge 10% After Q4 Results
  • Significant Stock Drop: Aveanna Healthcare (AVAH) shares fell approximately 10% on Thursday, marking its largest intraday decline in over a year, primarily due to its 2026 revenue outlook missing the midpoint of market consensus.
  • Revenue Guidance Maintained: Although the company maintained its 2026 revenue guidance between $2.54 billion and $2.56 billion, this forecast falls short of analysts' expectations of $2.56 billion, reflecting market concerns about future growth.
  • Earnings Beat Expectations: Aveanna's Q4 2025 revenue grew approximately 27% year-over-year to $662.5 million, driving full-year revenue up about 20% to $2.4 billion, indicating strong performance in the market.
  • Adjusted EBITDA Surge: The adjusted EBITDA for Q4 increased roughly 54% year-over-year to $85 million, exceeding the consensus estimate of $78.8 million, while the full-year adjusted EBITDA jumped about 75% to $320.9 million, showcasing a significant improvement in the company's profitability.
seekingalpha
9.5
03-19seekingalpha
Aveanna Healthcare Holdings Reports Strong Q4 Earnings and Maintains 2026 Guidance
  • Strong Earnings Report: Aveanna Healthcare Holdings reported a Q4 GAAP EPS of $0.80, beating estimates by $0.65, which highlights the company's significant improvement in profitability and boosts investor confidence.
  • Revenue Growth: The company achieved Q4 revenue of $662.5 million, representing a 27.4% year-over-year increase, surpassing market expectations by $13.02 million, indicating robust demand in the healthcare services sector.
  • 2026 Financial Guidance: Aveanna maintains its 2026 revenue guidance between $2.54 billion and $2.56 billion, aligning with the market consensus of $2.56 billion, demonstrating confidence in future growth prospects.
  • Adjusted EBITDA Outlook: The company also keeps its 2026 adjusted EBITDA guidance in the range of $318 million to $322 million, reflecting ongoing efforts in cost control and operational efficiency.
seekingalpha
9.5
03-18seekingalpha
Aveanna Healthcare Holdings Set to Release Q4 Earnings
  • Earnings Announcement: Aveanna Healthcare Holdings (AVAH) is set to announce its Q4 earnings on March 19 before market open, with consensus EPS estimate at $0.16, reflecting a substantial 220% year-over-year increase, and revenue expected at $649.48 million, up 24.9% year-over-year.
  • Consistent Outperformance: Over the past year, Aveanna has consistently beaten EPS and revenue estimates, demonstrating strong profitability and market adaptability, which enhances investor confidence in the stock.
  • Revisions Trend: In the last three months, EPS estimates have seen seven upward revisions with no downward adjustments, while revenue estimates experienced six upward revisions and one downward, indicating analysts' optimistic outlook on the company's future performance.
  • Acquisition Strategy: Aveanna plans to acquire Family First Homecare for $176 million, a move that will not only expand its market share but also strengthen its competitive position in the home healthcare sector, further driving company growth.
seekingalpha
8.5
03-12seekingalpha
Aveanna Healthcare Acquires Family First Homecare for $175.5M
  • Acquisition Agreement: Aveanna Healthcare announced an agreement to acquire Family First Homecare for $175.5 million, aiming to expand its geographic footprint in specialized care, with the transaction expected to close in Q2 2026.
  • Diverse Funding Sources: The acquisition will be funded through a combination of cash on hand and debt, demonstrating the company's flexibility in capital management and confidence in future growth.
  • Clear Market Positioning: Family First Homecare operates 27 locations across seven states, including Florida, focusing on private duty nursing services for the pediatric population, aligning with Aveanna's strategic mission to deliver high-quality care.
  • High Cultural Fit: Aveanna CEO Jeff Shaner emphasized that Family First Homecare is a tremendous cultural fit, which is expected to bring unprecedented value and clinical innovation to payors and stakeholders.
Wall Street analysts forecast AVAH stock price to rise
5 Analyst Rating
Wall Street analysts forecast AVAH stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
10.75
High
11.00
Current: 0.000
sliders
Low
10.00
Averages
10.75
High
11.00
Truist
David MacDonald
Hold
downgrade
$9 -> $8
AI Analysis
2026-04-13
Reason
Truist
David MacDonald
Price Target
$9 -> $8
AI Analysis
2026-04-13
downgrade
Hold
Reason
Truist analyst David MacDonald lowered the firm's price target on Aveanna to $8 from $9 and keeps a Hold rating on the shares as part of a broader research note previewing Q1 results in Healthcare Services, or HC. The firm remains broadly bullish on its HC Services coverage universe tied to continued strong demand trends, overarching secular tailwinds and more favorable/stable reimbursement backdrop, with the recent Final Medicare Advantage Rule seen as an "encouraging data point", the analyst tells investors in a research note. Truist adds that it continues to think the sector is well positioned given that it's scaled, domestic and defensive, also noting that the group is a beneficiary of AI/automation/interconnectivity, with strong free cash flow and attractive financial flexibility supporting the ongoing growth investment/M&A/shareholder friendly initiatives.
Barclays
Overweight
to
Overweight
downgrade
$11
2026-03-25
Reason
Barclays
Price Target
$11
2026-03-25
downgrade
Overweight
to
Overweight
Reason
Barclays lowered the firm's price target on Aveanna to $9.50 from $11 and keeps an Overweight rating on the shares. The firm revised models in the healthcare facilities and managed care group following the Q4 reports.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AVAH
Unlock Now

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH.O) is 10.73, compared to its 5-year average forward P/E of 38.34. For a more detailed relative valuation and DCF analysis to assess Aveanna Healthcare Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
38.34
Current PE
10.73
Overvalued PE
141.10
Undervalued PE
-64.42

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
12.26
Current EV/EBITDA
8.29
Overvalued EV/EBITDA
14.07
Undervalued EV/EBITDA
10.46

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.43
Current PS
0.52
Overvalued PS
0.71
Undervalued PS
0.15

Financials

AI Analysis
Annual
Quarterly

Whales Holding AVAH

J
Jaunty Global Limited
Holding
AVAH
+2.05%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Aveanna Healthcare Holdings Inc (AVAH) stock price today?

The current price of AVAH is 6.51 USD — it has increased 0.62

What is Aveanna Healthcare Holdings Inc (AVAH)'s business?

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.

What is the price predicton of AVAH Stock?

Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is10.75 USD with a low forecast of 10.00 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aveanna Healthcare Holdings Inc (AVAH)'s revenue for the last quarter?

Aveanna Healthcare Holdings Inc revenue for the last quarter amounts to 662.48M USD, increased 27.43

What is Aveanna Healthcare Holdings Inc (AVAH)'s earnings per share (EPS) for the last quarter?

Aveanna Healthcare Holdings Inc. EPS for the last quarter amounts to 0.80 USD, increased 433.33

How many employees does Aveanna Healthcare Holdings Inc (AVAH). have?

Aveanna Healthcare Holdings Inc (AVAH) has 3500 emplpoyees as of April 24 2026.

What is Aveanna Healthcare Holdings Inc (AVAH) market cap?

Today AVAH has the market capitalization of 1.42B USD.